Study of Digestive Tolerance of Orange Juice With Fibers
NCT ID: NCT01282983
Last Updated: 2011-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
200 participants
INTERVENTIONAL
2010-10-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?
NCT03032861
The Effect of 2 Months Daily Supplementation of Orange Juice With Fibers
NCT00966784
Evaluation of a New Orange-Based Beverage Enriched With Polyphenols in Adult Humans
NCT01290250
Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).
NCT02685124
Effects of Consumption of Orange Juice on Vascular Protection and Immune Function: Clinical Study on the Specific Contribution of Citrus Flavanones
NCT00983086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fiber
Fiber
The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) with 4grams of fiber in each pack.
Placebo
Placebo
The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) without fiber.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fiber
The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) with 4grams of fiber in each pack.
Placebo
The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) without fiber.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tolerate the intake of orange juice routinely (at least twice/month)
* Do not use antibiotics, industrial fibers or supplements containing industrialized fibers, prebiotics and probiotics for 30 days before the start of the study
* BMI between 18,5 a 29,9 Kg/m2
* Body weight stable during the last two months
* Able to have good communication with the researcher
* Understand and agree with the rules of the study
* Making use of some contraceptive method
* Non-smokers (less than five cigarettes/day)
Exclusion Criteria
* Severe alcoholics
* Allergy to orange and its juice
* Any other allergy or food intolerance
* Disease or disorder of the upper digestive tract diagnosed and treated in the last twelve months
* Inflammatory bowel diseases
* Irritable bowel syndrome
* To have diarrhea (three liquid evacuations a day)
* Pregnancy
* Lactation
* Any history of eating disorder
* Declared diseases:
* Renal insufficiency
* Hepatic Insufficiency
* Chronic Heart Failure
* Other disease which in the opinion of the investigator might be inconsistent with the study
* Be in dialysis process
* Chronic renal failure
* History or evidence of organic disease of the gastrointestinal tract
* History of cancer within five previous years (except basal cell carcinoma well treated or cervical carcinoma in situ)
* History or evidence of metabolic disturbs
* History of gastric surgery intervention (except appendectomy)
* Being under some weight loosing process or diet
* Refuse to sign the Informed Consent Term
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of São Paulo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan L Waitzberg, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of São Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IKEA2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.